Zynerba Pharmaceuticals, Inc. (ZYNE): Price and Financial Metrics

Zynerba Pharmaceuticals, Inc. (ZYNE)

Today's Latest Price: $5.70 USD

0.32 (-5.32%)

Updated Jan 17 12:00am

Add ZYNE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZYNE Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ZYNE is 0 -- better than just 7.07% of US stocks.
  • With a price/sales ratio of 1,661.62, Zynerba Pharmaceuticals Inc has a higher such ratio than 99.79% of stocks in our set.
  • With a year-over-year growth in debt of -41.08%, Zynerba Pharmaceuticals Inc's debt growth rate surpasses merely 7.72% of about US stocks.
  • Stocks that are quantitatively similar to ZYNE, based on their financial statements, market capitalization, and price volatility, are BPMX, RVNC, ADVM, PSTI, and PRTA.
  • Visit ZYNE's SEC page to see the company's official filings. To visit the company's web site, go to www.zynerba.com.
ZYNE Daily Price Range
ZYNE 52-Week Price Range

ZYNE Stock Price Chart More Charts

ZYNE Price/Volume Stats

Current price $5.70 52-week high $16.47
Prev. close $6.02 52-week low $3.56
Day low $5.63 Volume 808,400
Day high $6.10 Avg. volume 707,925
50-day MA $6.05 Dividend yield N/A
200-day MA $9.68 Market Cap 132.23M

Zynerba Pharmaceuticals, Inc. (ZYNE) Company Bio

Zynerba Pharmaceuticals is a specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. The company was founded in 2007 and is based in Devon, Pennsylvania.

ZYNE Latest News Stream

Event/Time News Detail
Loading, please wait...

ZYNE Latest Social Stream

Loading social stream, please wait...

View Full ZYNE Social Stream

ZYNE Price Returns

1-mo -8.21%
3-mo -28.84%
6-mo -50.35%
1-year 46.53%
3-year -68.54%
5-year N/A
YTD -5.63%
2019 103.37%
2018 -76.28%
2017 -19.69%
2016 54.82%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.569 seconds.